Fulgent GeneticsFLGT +0.14%64 Days Inventory is 20.82 as of Mar. 2026, which is 57% above its 10-year median of 13.22. GuruFocus rates FLGT with a GF Score™ of 64/100 and a GF Value™ of $24.05 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 177 Medical Diagnostics & Research companies, Fulgent Genetics ranks better than 85.88% on this metric.
The historical rank and industry rank for Fulgent Genetics's Days Inventory or its related term are showing as below:
FLGT'
s Days Inventory Range Over the Past 10 Years
Min: 7.65 Med: 13.22 Max: 34.07
Current: 18.71
During the past 12 years, Fulgent Genetics's highest Days Inventory was 34.07. The lowest was 7.65. And the median was 13.22.
FLGT's Days Inventory is ranked better than 85.88% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: 70.8
vs FLGT: 18.71
Fulgent Genetics's Days Inventory
increased
from Mar. 2025 (17.20) to Mar. 2026 (20.82).
It might indicate that Fulgent Genetics's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Fulgent Genetics's Inventory Turnover for the
three
months ended in Mar. 2026 was 4.38.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fulgent Genetics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.16.
Fulgent Genetics (NAS:FLGT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Fulgent Genetics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Fulgent Genetics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Fulgent Genetics Days Inventory Related Terms
Fulgent Genetics Days Inventory Historical Data
* Premium members only.
The historical data trend for Fulgent Genetics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FLGT vs MYGN, CSTL, BDSX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Fulgent Genetics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fulgent Genetics Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Fulgent Genetics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fulgent Genetics (FLGT) has a Days Inventory of 20.82 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Fulgent Genetics and its competitors. This is 57% above median its historical median of 13.22. Over the past decade, Fulgent Genetics' Days Inventory has ranged from 7.65 to 34.07. According to the industry distribution chart, Fulgent Genetics ranks #25 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 14.1%.
Is Fulgent Genetics' Days Inventory too high?
Fulgent Genetics' current Days Inventory of 20.82 is 57% above median its 10-year median of 13.22. Over the past 10 years, this metric has ranged from a low of 7.65 to a high of 34.07. The Medical Diagnostics & Research industry median Days Inventory is 70.80. Fulgent Genetics' value of 20.82 is 70.6% below this industry median. Based on the distribution chart, Fulgent Genetics ranks #25 out of 177 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Fulgent Genetics has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Days Inventory compare to MYGN and CSTL?
According to the Medical Diagnostics & Research industry distribution chart, Fulgent Genetics ranks #25 out of 177 companies for Days Inventory. This places Fulgent Genetics in the top 14% of its industry — outperforming the majority of peers. The industry median Days Inventory is 70.80. Fulgent Genetics' value of 20.82 is 70.6% below this benchmark. Historically, Fulgent Genetics' own Days Inventory has ranged from 7.65 to 34.07 over the past decade. While the company's 10-year median is 13.22 vs. the industry median of 70.80, Fulgent Genetics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 70.80, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fulgent Genetics's current Days Inventory of 20.82 is 70.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Fulgent Genetics and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 70.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fulgent Genetics's current Days Inventory is 20.82, which is 57% above median its own 10-year median of 13.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (FLGT) is currently considered Modestly Undervalued. The stock's GF Value™ is $24.05, compared to a current price of $20.86 — trading 13.3% below its estimated fair value. The current Days Inventory is 20.82, which is 57% above median its 10-year median of 13.22 and 70.6% below the Medical Diagnostics & Research industry median of 70.80. Fulgent Genetics' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Fulgent Genetics (FLGT), the current Days Inventory is 20.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fulgent Genetics (FLGT) Overvalued in 2026?
Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued.
The current stock price of $20.86 is trading 13.3% below its estimated GF Value™ of $24.05.
GuruFocus considers Fulgent Genetics to be Modestly Undervalued.
Key valuation signals for FLGT:
Days Inventory: 20.82 (57% above median its 10-year median of 13.22)
GF Value™: $24.05 vs. price of $20.86 (13.3% below fair value)
Industry Position: 70.6% below the Medical Diagnostics & Research median (#25 of 177)
No single metric tells the full story. See the FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
64GF Score
Get the complete analysis for FLGT
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FLGT has been successfully added to your 
